Skip to main content
Erschienen in: Current Heart Failure Reports 3/2018

08.04.2018 | Management of Heart Failure (T. Meyer, Section Editor)

Has the Time Come to Be More Aggressive With Bariatric Surgery in Obese Patients With Chronic Systolic Heart Failure?

verfasst von: Amanda R. Vest

Erschienen in: Current Heart Failure Reports | Ausgabe 3/2018

Einloggen, um Zugang zu erhalten

Abstract

Purpose of Review

Obesity is a strong risk factor for the development of heart failure (HF). Diet, exercise, and weight-loss pharmacotherapies have limited potential to achieve significant and sustainable weight loss, especially in patients with symptomatic systolic HF. This review seeks to determine the role of bariatric surgery for patients with systolic HF and obesity.

Recent Findings

Bariatric surgeries such as the laparoscopic sleeve gastrectomy (LSG) and Roux-en-Y gastric bypass (RYGB) represent the most successful long-term strategy for achieving weight loss and diabetes and hypertension remission in the general obese population. These benefits translate to reductions in cardiovascular events and mortality, as well as improvements in myocardial structure and function. There is also now data supporting the safety of LSG or RYGB in patients with systolic dysfunction and a reduction in HF admissions post-operatively.

Summary

Current literature and clinical experience suggest that the most appropriate bariatric surgery candidates with HF are patients aged < 50–60 years, with severely depressed systolic function and NYHA II-III symptoms, who have failed non-surgical strategies and have a high likelihood of future cardiac transplantation candidacy after weight loss. This review seeks to determine the role of bariatric surgery for patients with systolic HF and obesity.
Literatur
1.
Zurück zum Zitat Kenchaiah S, Evans JC, Levy D, Wilson PWF, Benjamin EJ, Larson MG, et al. Obesity and the risk of heart failure. N Engl J Med. 2002;347:305–13.CrossRefPubMed Kenchaiah S, Evans JC, Levy D, Wilson PWF, Benjamin EJ, Larson MG, et al. Obesity and the risk of heart failure. N Engl J Med. 2002;347:305–13.CrossRefPubMed
2.
Zurück zum Zitat Levitan EB, Yang AZ, Wolk A, Mittleman MA. Adiposity and incidence of heart failure hospitalization and mortality: a population-based prospective study. Circ Heart Fail. 2009;2:202–8.CrossRefPubMedPubMedCentral Levitan EB, Yang AZ, Wolk A, Mittleman MA. Adiposity and incidence of heart failure hospitalization and mortality: a population-based prospective study. Circ Heart Fail. 2009;2:202–8.CrossRefPubMedPubMedCentral
3.
Zurück zum Zitat Ho JE, Lyass A, Lee DS, Vasan RS, Kannel WB, Larson MG, et al. Predictors of new-onset heart failure: differences in preserved versus reduced ejection fraction. Circ Heart Fail. 2013;6:279–86.CrossRefPubMed Ho JE, Lyass A, Lee DS, Vasan RS, Kannel WB, Larson MG, et al. Predictors of new-onset heart failure: differences in preserved versus reduced ejection fraction. Circ Heart Fail. 2013;6:279–86.CrossRefPubMed
4.
Zurück zum Zitat Hales CM, Carroll MD, Fryar CD, Ogden CL. Prevalence of obesity among adults and youth: United States, 2015–2016. NCHS Data Brief. 2017;1–8. Hales CM, Carroll MD, Fryar CD, Ogden CL. Prevalence of obesity among adults and youth: United States, 2015–2016. NCHS Data Brief. 2017;1–8.
5.
Zurück zum Zitat • Joyce E, Lala A, Stevens SR, Cooper LB, Abouezzeddine OF, Groarke JD, et al. Prevalence, profile, and prognosis of severe obesity in contemporary hospitalized heart failure trial populations. JACC Heart Fail. 2016;4:923–31. This report describes the BMI distribution in contemporary Heart Failure Network inpatient clinical trials and reveals a high prevalence of obesity in HF. Subjects with BMI ≥ 40 kg/m 2 were younger, more often female, hypertensive, diabetic, and more likely to have HFpEF. CrossRefPubMed • Joyce E, Lala A, Stevens SR, Cooper LB, Abouezzeddine OF, Groarke JD, et al. Prevalence, profile, and prognosis of severe obesity in contemporary hospitalized heart failure trial populations. JACC Heart Fail. 2016;4:923–31. This report describes the BMI distribution in contemporary Heart Failure Network inpatient clinical trials and reveals a high prevalence of obesity in HF. Subjects with BMI ≥ 40 kg/m 2 were younger, more often female, hypertensive, diabetic, and more likely to have HFpEF. CrossRefPubMed
6.
Zurück zum Zitat Mehra MR, Canter CE, Hannan MM, Semigran MJ, Uber PA, Baran DA, et al. The 2016 International Society for Heart Lung Transplantation listing criteria for heart transplantation: a 10-year update. J Heart Lung Transplant. 2016;35:1–23.CrossRefPubMed Mehra MR, Canter CE, Hannan MM, Semigran MJ, Uber PA, Baran DA, et al. The 2016 International Society for Heart Lung Transplantation listing criteria for heart transplantation: a 10-year update. J Heart Lung Transplant. 2016;35:1–23.CrossRefPubMed
7.
Zurück zum Zitat Oreopoulos A, Ezekowitz JA, McAlister FA, Kalantar-Zadeh K, Fonarow GC, Norris CM, et al. Association between direct measures of body composition and prognostic factors in chronic heart failure. Mayo Clin Proc. 2010;85:609–17.CrossRefPubMedPubMedCentral Oreopoulos A, Ezekowitz JA, McAlister FA, Kalantar-Zadeh K, Fonarow GC, Norris CM, et al. Association between direct measures of body composition and prognostic factors in chronic heart failure. Mayo Clin Proc. 2010;85:609–17.CrossRefPubMedPubMedCentral
8.
Zurück zum Zitat St Peter JV, Hartley GG, Murakami MM, Apple FS. B-type natriuretic peptide (BNP) and N-terminal pro-BNP in obese patients without heart failure: relationship to body mass index and gastric bypass surgery. Clin Chem. 2006;52:680–5.CrossRefPubMed St Peter JV, Hartley GG, Murakami MM, Apple FS. B-type natriuretic peptide (BNP) and N-terminal pro-BNP in obese patients without heart failure: relationship to body mass index and gastric bypass surgery. Clin Chem. 2006;52:680–5.CrossRefPubMed
9.
Zurück zum Zitat Curtis JP, Selter JG, Wang Y, Rathore SS, Jovin IS, Jadbabaie F, et al. The obesity paradox: body mass index and outcomes in patients with heart failure. Arch Intern Med. 2005;165:55–61.CrossRefPubMed Curtis JP, Selter JG, Wang Y, Rathore SS, Jovin IS, Jadbabaie F, et al. The obesity paradox: body mass index and outcomes in patients with heart failure. Arch Intern Med. 2005;165:55–61.CrossRefPubMed
10.
Zurück zum Zitat Oreopoulos A, Padwal R, Kalantar-Zadeh K, Fonarow GC, Norris CM, McAlister FA. Body mass index and mortality in heart failure: a meta-analysis. Am Heart J. 2008;156:13–22.CrossRefPubMed Oreopoulos A, Padwal R, Kalantar-Zadeh K, Fonarow GC, Norris CM, McAlister FA. Body mass index and mortality in heart failure: a meta-analysis. Am Heart J. 2008;156:13–22.CrossRefPubMed
11.
Zurück zum Zitat Pocock SJ, McMurray JJV, Dobson J, Yusuf S, Granger CB, Michelson EL, et al. Weight loss and mortality risk in patients with chronic heart failure in the candesartan in heart failure: assessment of reduction in mortality and morbidity (CHARM) programme. Eur Heart J. 2008;29:2641–50.CrossRefPubMed Pocock SJ, McMurray JJV, Dobson J, Yusuf S, Granger CB, Michelson EL, et al. Weight loss and mortality risk in patients with chronic heart failure in the candesartan in heart failure: assessment of reduction in mortality and morbidity (CHARM) programme. Eur Heart J. 2008;29:2641–50.CrossRefPubMed
12.
Zurück zum Zitat Lavie CJ, Milani RV, Ventura HO. Obesity and cardiovascular disease: risk factor, paradox, and impact of weight loss. J Am Coll Cardiol. 2009;53:1925–32.CrossRefPubMed Lavie CJ, Milani RV, Ventura HO. Obesity and cardiovascular disease: risk factor, paradox, and impact of weight loss. J Am Coll Cardiol. 2009;53:1925–32.CrossRefPubMed
13.
Zurück zum Zitat Voulgari C, Tentolouris N, Dilaveris P, Tousoulis D, Katsilambros N, Stefanadis C. Increased heart failure risk in normal-weight people with metabolic syndrome compared with metabolically healthy obese individuals. J Am Coll Cardiol. 2011;58:1343–50.CrossRefPubMed Voulgari C, Tentolouris N, Dilaveris P, Tousoulis D, Katsilambros N, Stefanadis C. Increased heart failure risk in normal-weight people with metabolic syndrome compared with metabolically healthy obese individuals. J Am Coll Cardiol. 2011;58:1343–50.CrossRefPubMed
14.
Zurück zum Zitat Li X, Li S, Ulusoy E, Chen W, Srinivasan SR, Berenson GS. Childhood adiposity as a predictor of cardiac mass in adulthood: the Bogalusa heart study. Circulation. 2004;110:3488–92.CrossRefPubMed Li X, Li S, Ulusoy E, Chen W, Srinivasan SR, Berenson GS. Childhood adiposity as a predictor of cardiac mass in adulthood: the Bogalusa heart study. Circulation. 2004;110:3488–92.CrossRefPubMed
15.
Zurück zum Zitat van Putte-Katier N, Rooman RP, Haas L, Verhulst SL, Desager KN, Ramet J, et al. Early cardiac abnormalities in obese children: importance of obesity per se versus associated cardiovascular risk factors. Pediatr Res. 2008;64:205–9.CrossRefPubMed van Putte-Katier N, Rooman RP, Haas L, Verhulst SL, Desager KN, Ramet J, et al. Early cardiac abnormalities in obese children: importance of obesity per se versus associated cardiovascular risk factors. Pediatr Res. 2008;64:205–9.CrossRefPubMed
16.
Zurück zum Zitat Mehta S, Holliday C, Hayduk L, Wiersma L, Ricahrds N, Younoszai A. Comparison of myocardial function in children with body mass indexes ≥ 25 versus those < 25 kg/m2. Am J Cardiol. 2004;93:1567–9.CrossRefPubMed Mehta S, Holliday C, Hayduk L, Wiersma L, Ricahrds N, Younoszai A. Comparison of myocardial function in children with body mass indexes ≥ 25 versus those < 25 kg/m2. Am J Cardiol. 2004;93:1567–9.CrossRefPubMed
17.
Zurück zum Zitat Chinali M, de Simone G, Roman MJ, Lee ET, Best LG, Howard BV, et al. Impact of obesity on cardiac geometry and function in a population of adolescents. J Am Coll Cardiol. 2006;47:2267–73.CrossRefPubMed Chinali M, de Simone G, Roman MJ, Lee ET, Best LG, Howard BV, et al. Impact of obesity on cardiac geometry and function in a population of adolescents. J Am Coll Cardiol. 2006;47:2267–73.CrossRefPubMed
18.
Zurück zum Zitat Saltijeral A, de Isla LP, Pérez-Rodríguez O, Rueda S, Fernandez-Golfin C, Almeria C, et al. Early myocardial deformation changes associated to isolated obesity: a study based on 3D-wall motion tracking analysis. Obesity. 2011;19:2268–73.CrossRefPubMed Saltijeral A, de Isla LP, Pérez-Rodríguez O, Rueda S, Fernandez-Golfin C, Almeria C, et al. Early myocardial deformation changes associated to isolated obesity: a study based on 3D-wall motion tracking analysis. Obesity. 2011;19:2268–73.CrossRefPubMed
19.
Zurück zum Zitat Cozzolino D, Grandone A, Cittadini A, Palmiero G, Esposito G, De Bellis A, et al. Subclinical myocardial dysfunction and cardiac autonomic dysregulation are closely associated in obese children and adolescents: the potential role of insulin resistance. PLoS One. 2015;10:e0123916.CrossRefPubMedPubMedCentral Cozzolino D, Grandone A, Cittadini A, Palmiero G, Esposito G, De Bellis A, et al. Subclinical myocardial dysfunction and cardiac autonomic dysregulation are closely associated in obese children and adolescents: the potential role of insulin resistance. PLoS One. 2015;10:e0123916.CrossRefPubMedPubMedCentral
20.
Zurück zum Zitat Ippisch HM, Inge TH, Daniels SR, Wang B, Khoury PR, Witt SA, et al. Reversibility of cardiac abnormalities in morbidly obese adolescents. J Am Coll Cardiol. 2008;51:1342–8.CrossRefPubMed Ippisch HM, Inge TH, Daniels SR, Wang B, Khoury PR, Witt SA, et al. Reversibility of cardiac abnormalities in morbidly obese adolescents. J Am Coll Cardiol. 2008;51:1342–8.CrossRefPubMed
21.
Zurück zum Zitat Michalsky MP, Raman SV, Teich S, Schuster DP, Bauer JA. Cardiovascular recovery following bariatric surgery in extremely obese adolescents: preliminary results using cardiac magnetic resonance (CMR) imaging. J Pediatr Surg. 2013;48:170–7.CrossRefPubMed Michalsky MP, Raman SV, Teich S, Schuster DP, Bauer JA. Cardiovascular recovery following bariatric surgery in extremely obese adolescents: preliminary results using cardiac magnetic resonance (CMR) imaging. J Pediatr Surg. 2013;48:170–7.CrossRefPubMed
22.
Zurück zum Zitat Barbosa MM, Beleigoli AM, de Fatima DM, Freire CV, Ribeiro AL, Nunes MCP. Strain imaging in morbid obesity: insights into subclinical ventricular dysfunction. Clin Cardiol. 2011;34:288–93.CrossRefPubMed Barbosa MM, Beleigoli AM, de Fatima DM, Freire CV, Ribeiro AL, Nunes MCP. Strain imaging in morbid obesity: insights into subclinical ventricular dysfunction. Clin Cardiol. 2011;34:288–93.CrossRefPubMed
23.
Zurück zum Zitat Orhan AL, Uslu N, Dayi SU, Nurkalem Z, Uzun F, Erer HB, et al. Effects of isolated obesity on left and right ventricular function: a tissue Doppler and strain rate imaging study. Echocardiography. 2010;27:236–43.CrossRefPubMed Orhan AL, Uslu N, Dayi SU, Nurkalem Z, Uzun F, Erer HB, et al. Effects of isolated obesity on left and right ventricular function: a tissue Doppler and strain rate imaging study. Echocardiography. 2010;27:236–43.CrossRefPubMed
25.
Zurück zum Zitat Mattu HS, Randeva HS. Role of adipokines in cardiovascular disease. J Endocrinol. 2013;216:T17–36.CrossRefPubMed Mattu HS, Randeva HS. Role of adipokines in cardiovascular disease. J Endocrinol. 2013;216:T17–36.CrossRefPubMed
27.
Zurück zum Zitat Ukkola O, Santaniemi M. Adiponectin: a link between excess adiposity and associated comorbidities? J Mol Med. 2002;80:696–702.CrossRefPubMed Ukkola O, Santaniemi M. Adiponectin: a link between excess adiposity and associated comorbidities? J Mol Med. 2002;80:696–702.CrossRefPubMed
28.
Zurück zum Zitat Han SH, Quon MJ, Kim J-A, Koh KK. Adiponectin and cardiovascular disease: response to therapeutic interventions. J Am Coll Cardiol. 2007;49:531–8.CrossRefPubMed Han SH, Quon MJ, Kim J-A, Koh KK. Adiponectin and cardiovascular disease: response to therapeutic interventions. J Am Coll Cardiol. 2007;49:531–8.CrossRefPubMed
29.
Zurück zum Zitat Van Berendoncks AM, Garnier A, Beckers P, Hoymans VY, Possemiers N, Fortin D, et al. Functional adiponectin resistance at the level of the skeletal muscle in mild to moderate chronic heart failure. Circ Heart Fail. 2010;3:185–94.CrossRefPubMed Van Berendoncks AM, Garnier A, Beckers P, Hoymans VY, Possemiers N, Fortin D, et al. Functional adiponectin resistance at the level of the skeletal muscle in mild to moderate chronic heart failure. Circ Heart Fail. 2010;3:185–94.CrossRefPubMed
30.
Zurück zum Zitat Baker AR, Silva NFD, Quinn DW, Harte AL, Pagano D, Bonser RS, et al. Human epicardial adipose tissue expresses a pathogenic profile of adipocytokines in patients with cardiovascular disease. Cardiovasc Diabetol. 2006;5:1.CrossRefPubMedPubMedCentral Baker AR, Silva NFD, Quinn DW, Harte AL, Pagano D, Bonser RS, et al. Human epicardial adipose tissue expresses a pathogenic profile of adipocytokines in patients with cardiovascular disease. Cardiovasc Diabetol. 2006;5:1.CrossRefPubMedPubMedCentral
31.
Zurück zum Zitat Perego L, Pizzocri P, Corradi D, Maisano F, Paganelli M, Fiorina P, et al. Circulating leptin correlates with left ventricular mass in morbid (grade III) obesity before and after weight loss induced by bariatric surgery: a potential role for leptin in mediating human left ventricular hypertrophy. J Clin Endocrinol Metab. 2005;90:4087–93.CrossRefPubMed Perego L, Pizzocri P, Corradi D, Maisano F, Paganelli M, Fiorina P, et al. Circulating leptin correlates with left ventricular mass in morbid (grade III) obesity before and after weight loss induced by bariatric surgery: a potential role for leptin in mediating human left ventricular hypertrophy. J Clin Endocrinol Metab. 2005;90:4087–93.CrossRefPubMed
32.
Zurück zum Zitat Konstantinides S, Schafer K, Loskutoff DJ. The prothrombotic effects of leptin possible implications for the risk of cardiovascular disease in obesity. Ann N Y Acad Sci. 2001;947:134–41. discussion 141–2CrossRefPubMed Konstantinides S, Schafer K, Loskutoff DJ. The prothrombotic effects of leptin possible implications for the risk of cardiovascular disease in obesity. Ann N Y Acad Sci. 2001;947:134–41. discussion 141–2CrossRefPubMed
33.
Zurück zum Zitat Tretjakovs P, Jurka A, Bormane I, Mackevics V, Mikelsone I, Balode L, et al. Relation of inflammatory chemokines to insulin resistance and hypoadiponectinemia in coronary artery disease patients. Eur J Intern Med. 2009;20:712–7.CrossRefPubMed Tretjakovs P, Jurka A, Bormane I, Mackevics V, Mikelsone I, Balode L, et al. Relation of inflammatory chemokines to insulin resistance and hypoadiponectinemia in coronary artery disease patients. Eur J Intern Med. 2009;20:712–7.CrossRefPubMed
34.
Zurück zum Zitat Schulze PC, Kratzsch J, Linke A, Schoene N, Adams V, Gielen S, et al. Elevated serum levels of leptin and soluble leptin receptor in patients with advanced chronic heart failure. Eur J Heart Fail. 2003;5:33–40.CrossRefPubMed Schulze PC, Kratzsch J, Linke A, Schoene N, Adams V, Gielen S, et al. Elevated serum levels of leptin and soluble leptin receptor in patients with advanced chronic heart failure. Eur J Heart Fail. 2003;5:33–40.CrossRefPubMed
35.
Zurück zum Zitat Martin SS, Qasim A, Reilly MP. Leptin resistance: a possible interface of inflammation and metabolism in obesity-related cardiovascular disease. J Am Coll Cardiol. 2008;52:1201–10.CrossRefPubMedPubMedCentral Martin SS, Qasim A, Reilly MP. Leptin resistance: a possible interface of inflammation and metabolism in obesity-related cardiovascular disease. J Am Coll Cardiol. 2008;52:1201–10.CrossRefPubMedPubMedCentral
36.
Zurück zum Zitat Wannamethee SG, Shaper AG, Whincup PH, Lennon L, Sattar N. Obesity and risk of incident heart failure in older men with and without pre-existing coronary heart disease: does leptin have a role? J Am Coll Cardiol. 2011;58:1870–7.CrossRefPubMed Wannamethee SG, Shaper AG, Whincup PH, Lennon L, Sattar N. Obesity and risk of incident heart failure in older men with and without pre-existing coronary heart disease: does leptin have a role? J Am Coll Cardiol. 2011;58:1870–7.CrossRefPubMed
37.
Zurück zum Zitat Smith CCT, Dixon RA, Wynne AM, Theodorou L, Ong S-G, Subrayan S, et al. Leptin-induced cardioprotection involves JAK/STAT signaling that may be linked to the mitochondrial permeability transition pore. AJP: Heart Circ Physiol. 2010;299:H1265–70. Smith CCT, Dixon RA, Wynne AM, Theodorou L, Ong S-G, Subrayan S, et al. Leptin-induced cardioprotection involves JAK/STAT signaling that may be linked to the mitochondrial permeability transition pore. AJP: Heart Circ Physiol. 2010;299:H1265–70.
38.
Zurück zum Zitat Nagaya N, Uematsu M, Kojima M, Ikeda Y, Yoshihara F, Shimizu W, et al. Chronic administration of ghrelin improves left ventricular dysfunction and attenuates development of cardiac cachexia in rats with heart failure. Circulation. 2001;104:1430–5.CrossRefPubMed Nagaya N, Uematsu M, Kojima M, Ikeda Y, Yoshihara F, Shimizu W, et al. Chronic administration of ghrelin improves left ventricular dysfunction and attenuates development of cardiac cachexia in rats with heart failure. Circulation. 2001;104:1430–5.CrossRefPubMed
39.
Zurück zum Zitat Nagaya N, Moriya J, Yasumura Y, Uematsu M, Ono F, Shimizu W, et al. Effects of ghrelin administration on left ventricular function, exercise capacity, and muscle wasting in patients with chronic heart failure. Circulation. 2004;110:3674–9.CrossRefPubMed Nagaya N, Moriya J, Yasumura Y, Uematsu M, Ono F, Shimizu W, et al. Effects of ghrelin administration on left ventricular function, exercise capacity, and muscle wasting in patients with chronic heart failure. Circulation. 2004;110:3674–9.CrossRefPubMed
40.
Zurück zum Zitat Nikolaidis LA, Mankad S, Sokos GG, Miske G, Shah A, Elahi D, et al. Effects of glucagon-like peptide-1 in patients with acute myocardial infarction and left ventricular dysfunction after successful reperfusion. Circulation. 2004;109:962–5.CrossRefPubMed Nikolaidis LA, Mankad S, Sokos GG, Miske G, Shah A, Elahi D, et al. Effects of glucagon-like peptide-1 in patients with acute myocardial infarction and left ventricular dysfunction after successful reperfusion. Circulation. 2004;109:962–5.CrossRefPubMed
41.
Zurück zum Zitat Sokos GG, Nikolaidis LA, Mankad S, Elahi D, Shannon RP. Glucagon-like peptide-1 infusion improves left ventricular ejection fraction and functional status in patients with chronic heart failure. J Card Fail. 2006;12:694–9.CrossRefPubMed Sokos GG, Nikolaidis LA, Mankad S, Elahi D, Shannon RP. Glucagon-like peptide-1 infusion improves left ventricular ejection fraction and functional status in patients with chronic heart failure. J Card Fail. 2006;12:694–9.CrossRefPubMed
42.
Zurück zum Zitat Nathanson D, Ullman B, Löfström U, Hedman A, Frick M, Sjöholm A, et al. Effects of intravenous exenatide in type 2 diabetic patients with congestive heart failure: a double-blind, randomised controlled clinical trial of efficacy and safety. Diabetologia. 2012;55:926–35.CrossRefPubMed Nathanson D, Ullman B, Löfström U, Hedman A, Frick M, Sjöholm A, et al. Effects of intravenous exenatide in type 2 diabetic patients with congestive heart failure: a double-blind, randomised controlled clinical trial of efficacy and safety. Diabetologia. 2012;55:926–35.CrossRefPubMed
43.
Zurück zum Zitat Margulies KB, Hernandez AF, Redfield MM, Givertz MM, Oliveira GH, Cole R, et al. For the NHLBI heart failure clinical research network. Effects of liraglutide on clinical stability among patients with advanced heart failure and reduced ejection fraction. JAMA. 2016;316:500–8.CrossRefPubMedPubMedCentral Margulies KB, Hernandez AF, Redfield MM, Givertz MM, Oliveira GH, Cole R, et al. For the NHLBI heart failure clinical research network. Effects of liraglutide on clinical stability among patients with advanced heart failure and reduced ejection fraction. JAMA. 2016;316:500–8.CrossRefPubMedPubMedCentral
44.
Zurück zum Zitat Vest AR, Heneghan HM, Schauer PR, Young JB. Surgical management of obesity and the relationship to cardiovascular disease. Circulation. 2013;127:945–59.CrossRefPubMed Vest AR, Heneghan HM, Schauer PR, Young JB. Surgical management of obesity and the relationship to cardiovascular disease. Circulation. 2013;127:945–59.CrossRefPubMed
45.
Zurück zum Zitat Esteban Varela J, Nguyen NT. Laparoscopic sleeve gastrectomy leads the U.S. utilization of bariatric surgery at academic medical centers. Surg Obes Relat Dis. 2015;11:987–90.CrossRefPubMed Esteban Varela J, Nguyen NT. Laparoscopic sleeve gastrectomy leads the U.S. utilization of bariatric surgery at academic medical centers. Surg Obes Relat Dis. 2015;11:987–90.CrossRefPubMed
46.
Zurück zum Zitat NIH conference. Gastrointestinal surgery for severe obesity. Consensus Development Conference Panel 1991. p. 956–961. NIH conference. Gastrointestinal surgery for severe obesity. Consensus Development Conference Panel 1991. p. 956–961.
47.
Zurück zum Zitat Brito JP, Montori VM, Davis AM. Metabolic surgery in the treatment algorithm for type 2 diabetes: a joint statement by international diabetes organizations. JAMA. 2017;317:635–6.CrossRefPubMedPubMedCentral Brito JP, Montori VM, Davis AM. Metabolic surgery in the treatment algorithm for type 2 diabetes: a joint statement by international diabetes organizations. JAMA. 2017;317:635–6.CrossRefPubMedPubMedCentral
48.
Zurück zum Zitat Poirier P, Cornier MA, Mazzone T, Stiles S, Cummings S, Klein S, et al. On behalf of the American Heart Association obesity Committee of the Council on nutrition, physical activity, and metabolism. Bariatric surgery and cardiovascular risk factors: a scientific statement from the American Heart Association. Circulation. 2011;123:1683–701.CrossRefPubMed Poirier P, Cornier MA, Mazzone T, Stiles S, Cummings S, Klein S, et al. On behalf of the American Heart Association obesity Committee of the Council on nutrition, physical activity, and metabolism. Bariatric surgery and cardiovascular risk factors: a scientific statement from the American Heart Association. Circulation. 2011;123:1683–701.CrossRefPubMed
49.
Zurück zum Zitat Buchwald H, Avidor Y, Braunwald E, Jensen MD, Pories W, Fahrbach K, et al. Bariatric surgery. JAMA. 2004;292:1724–37.CrossRefPubMed Buchwald H, Avidor Y, Braunwald E, Jensen MD, Pories W, Fahrbach K, et al. Bariatric surgery. JAMA. 2004;292:1724–37.CrossRefPubMed
50.
Zurück zum Zitat • Adams TD, Davidson LE, Litwin SE, Kim J, Kolotkin RL, Nanjee MN, et al. Weight and metabolic outcomes 12 years after gastric bypass. N Engl J Med. 2017;377:1143–55. This 12-year observational study describes clinical outcomes for 1156 patients with severe obesity who either underwent RYGB, sought but did not undergo surgery or did not seek surgery. It shows long-term durability of surgical weight loss and sustained remission of type 2 diabetes, hypertension and hyperlipidemia, with 51% of patients with pre-operative diabetes have sustained diabetes remission at 12 years. CrossRefPubMedPubMedCentral • Adams TD, Davidson LE, Litwin SE, Kim J, Kolotkin RL, Nanjee MN, et al. Weight and metabolic outcomes 12 years after gastric bypass. N Engl J Med. 2017;377:1143–55. This 12-year observational study describes clinical outcomes for 1156 patients with severe obesity who either underwent RYGB, sought but did not undergo surgery or did not seek surgery. It shows long-term durability of surgical weight loss and sustained remission of type 2 diabetes, hypertension and hyperlipidemia, with 51% of patients with pre-operative diabetes have sustained diabetes remission at 12 years. CrossRefPubMedPubMedCentral
51.
Zurück zum Zitat Vest AR, Heneghan HM, Agarwal S, Schauer PR, Young JB. Bariatric surgery and cardiovascular outcomes: a systematic review. Heart. 2012;98:1763–77.CrossRefPubMed Vest AR, Heneghan HM, Agarwal S, Schauer PR, Young JB. Bariatric surgery and cardiovascular outcomes: a systematic review. Heart. 2012;98:1763–77.CrossRefPubMed
52.
Zurück zum Zitat Schauer PR, Kashyap SR, Wolski K, Brethauer SA, Kirwan JP, Pothier CE, et al. Bariatric surgery versus intensive medical therapy in obese patients with diabetes. N Engl J Med. 2012;366:1577–85.CrossRef Schauer PR, Kashyap SR, Wolski K, Brethauer SA, Kirwan JP, Pothier CE, et al. Bariatric surgery versus intensive medical therapy in obese patients with diabetes. N Engl J Med. 2012;366:1577–85.CrossRef
53.
Zurück zum Zitat • Schauer PR, Bhatt DL, Kirwan JP, Wolski K, Aminian A, Brethauer SA, et al. Bariatric surgery versus intensive medical therapy for diabetes—5-year outcomes. N Engl J Med. 2017;376:641–51. The most recent STAMPEDE report describes the outcomes at 5 years after randomization to optimal medical therapy vs RYGB vs laparoscopic sleeve gastrectomy for type 2 diabetes control. The surgical groups achieved the greatest remission from diabetes as well as the more favorable weight loss and quality of life profiles. CrossRefPubMedPubMedCentral • Schauer PR, Bhatt DL, Kirwan JP, Wolski K, Aminian A, Brethauer SA, et al. Bariatric surgery versus intensive medical therapy for diabetes—5-year outcomes. N Engl J Med. 2017;376:641–51. The most recent STAMPEDE report describes the outcomes at 5 years after randomization to optimal medical therapy vs RYGB vs laparoscopic sleeve gastrectomy for type 2 diabetes control. The surgical groups achieved the greatest remission from diabetes as well as the more favorable weight loss and quality of life profiles. CrossRefPubMedPubMedCentral
54.
Zurück zum Zitat Carlsson LMS, Peltonen M, Ahlin S, Anveden Å, Bouchard C, Carlsson B, et al. Bariatric surgery and prevention of type 2 diabetes in Swedish obese subjects. N Engl J Med. 2012;367:695–704.CrossRefPubMed Carlsson LMS, Peltonen M, Ahlin S, Anveden Å, Bouchard C, Carlsson B, et al. Bariatric surgery and prevention of type 2 diabetes in Swedish obese subjects. N Engl J Med. 2012;367:695–704.CrossRefPubMed
55.
Zurück zum Zitat Longitudinal Assessment of Bariatric Surgery (LABS) Consortium, Flum DR, Belle SH, King WC, Wahed AS, Berk P, et al. Perioperative safety in the longitudinal assessment of bariatric surgery. N Engl J Med. 2009;361:445–54.CrossRef Longitudinal Assessment of Bariatric Surgery (LABS) Consortium, Flum DR, Belle SH, King WC, Wahed AS, Berk P, et al. Perioperative safety in the longitudinal assessment of bariatric surgery. N Engl J Med. 2009;361:445–54.CrossRef
56.
57.
Zurück zum Zitat •• Vest AR, Patel P, Schauer PR, Satava ME, Cavalcante JL, Brethauer S, et al. Clinical and echocardiographic outcomes after bariatric surgery in obese patients with left ventricular systolic dysfunction. Circ Heart Fail. 2016;9:e002260. This retrospective cohort study was the first to report the weight loss efficacy and surgical safety of bariatric procedures in patients with left ventricular systolic dysfunction as compared to the general bariatric population. An echocardiographic subgroup showed a modest improvement in left ventricular ejection fraction in patients with systolic dysfunction who underwent bariatric surgery, with ejection fraction improvement more likely in patients without a baseline history of myocardial infarction. CrossRefPubMed •• Vest AR, Patel P, Schauer PR, Satava ME, Cavalcante JL, Brethauer S, et al. Clinical and echocardiographic outcomes after bariatric surgery in obese patients with left ventricular systolic dysfunction. Circ Heart Fail. 2016;9:e002260. This retrospective cohort study was the first to report the weight loss efficacy and surgical safety of bariatric procedures in patients with left ventricular systolic dysfunction as compared to the general bariatric population. An echocardiographic subgroup showed a modest improvement in left ventricular ejection fraction in patients with systolic dysfunction who underwent bariatric surgery, with ejection fraction improvement more likely in patients without a baseline history of myocardial infarction. CrossRefPubMed
58.
Zurück zum Zitat Morino M, Toppino M, Forestieri P, Angrisani L, Allaix ME, Scopinaro N. Mortality after bariatric surgery: analysis of 13,871 morbidly obese patients from a national registry. Ann Surg. 2007;246:1002–7. discussion 1007–9CrossRefPubMed Morino M, Toppino M, Forestieri P, Angrisani L, Allaix ME, Scopinaro N. Mortality after bariatric surgery: analysis of 13,871 morbidly obese patients from a national registry. Ann Surg. 2007;246:1002–7. discussion 1007–9CrossRefPubMed
59.
Zurück zum Zitat Ma IT, Madura JA. Gastrointestinal complications after bariatric surgery. Gastroenterol Hepatol. 2015;11:526–35. Ma IT, Madura JA. Gastrointestinal complications after bariatric surgery. Gastroenterol Hepatol. 2015;11:526–35.
60.
Zurück zum Zitat Triantafyllidis G, Lazoura O, Sioka E, Tzovaras G, Antoniou A, Vassiou K, et al. Anatomy and complications following laparoscopic sleeve gastrectomy: radiological evaluation and imaging pitfalls. Obes Surg. 2010;21:473–8.CrossRef Triantafyllidis G, Lazoura O, Sioka E, Tzovaras G, Antoniou A, Vassiou K, et al. Anatomy and complications following laparoscopic sleeve gastrectomy: radiological evaluation and imaging pitfalls. Obes Surg. 2010;21:473–8.CrossRef
61.
Zurück zum Zitat Zhang Y, Wang J, Ju W, Sun X, Cao Z, Cao Z, et al. Laparoscopic sleeve gastrectomy versus laparoscopic roux-en-Y gastric bypass for morbid obesity and related comorbidities: a meta-analysis of 21 studies. Obes Surg. 2015;25:19–26.CrossRefPubMed Zhang Y, Wang J, Ju W, Sun X, Cao Z, Cao Z, et al. Laparoscopic sleeve gastrectomy versus laparoscopic roux-en-Y gastric bypass for morbid obesity and related comorbidities: a meta-analysis of 21 studies. Obes Surg. 2015;25:19–26.CrossRefPubMed
62.
Zurück zum Zitat Maxwell BG, Ingrande J, Rosenthal DN, Ramamoorthy C. Perioperative management of the morbidly obese adolescent with heart failure undergoing bariatric surgery. Pediatr Anesth. 2012;22:476–82.CrossRef Maxwell BG, Ingrande J, Rosenthal DN, Ramamoorthy C. Perioperative management of the morbidly obese adolescent with heart failure undergoing bariatric surgery. Pediatr Anesth. 2012;22:476–82.CrossRef
63.
Zurück zum Zitat Kopp HP. Impact of weight loss on inflammatory proteins and their association with the insulin resistance syndrome in morbidly obese patients. Arterioscl Throm Vas. 2003;23:1042–7.CrossRef Kopp HP. Impact of weight loss on inflammatory proteins and their association with the insulin resistance syndrome in morbidly obese patients. Arterioscl Throm Vas. 2003;23:1042–7.CrossRef
64.
Zurück zum Zitat Luaces M, Cachofeiro V, García-Muñoz-Najar A, Medina M, González N, Cancer E, et al. Anatomical and functional alterations of the heart in morbid obesity. Changes after bariatric surgery. Rev Esp Cardiol. 2012;65:14–21.CrossRefPubMed Luaces M, Cachofeiro V, García-Muñoz-Najar A, Medina M, González N, Cancer E, et al. Anatomical and functional alterations of the heart in morbid obesity. Changes after bariatric surgery. Rev Esp Cardiol. 2012;65:14–21.CrossRefPubMed
65.
Zurück zum Zitat Woelnerhanssen B, Peterli R, Steinert RE, Peters T, Borbély Y, Beglinger C. Effects of postbariatric surgery weight loss on adipokines and metabolic parameters: comparison of laparoscopic roux-en-Y gastric bypass and laparoscopic sleeve gastrectomy—a prospective randomized trial. Surg Obes Relat Dis. 2011;7:561–8.CrossRefPubMed Woelnerhanssen B, Peterli R, Steinert RE, Peters T, Borbély Y, Beglinger C. Effects of postbariatric surgery weight loss on adipokines and metabolic parameters: comparison of laparoscopic roux-en-Y gastric bypass and laparoscopic sleeve gastrectomy—a prospective randomized trial. Surg Obes Relat Dis. 2011;7:561–8.CrossRefPubMed
66.
Zurück zum Zitat Leichman JG, Aguilar D, King TM, Mehta S, Majka C, Scarborough T, et al. Improvements in systemic metabolism, anthropometrics, and left ventricular geometry 3 months after bariatric surgery. Surg Obes Relat Dis. 2006;2:592–9.CrossRefPubMedPubMedCentral Leichman JG, Aguilar D, King TM, Mehta S, Majka C, Scarborough T, et al. Improvements in systemic metabolism, anthropometrics, and left ventricular geometry 3 months after bariatric surgery. Surg Obes Relat Dis. 2006;2:592–9.CrossRefPubMedPubMedCentral
67.
Zurück zum Zitat Rider OJ, Francis JM, Ali MK, Petersen SE, Robinson M, Robson MD, et al. Beneficial cardiovascular effects of bariatric surgical and dietary weight loss in obesity. J Am Coll Cardiol. 2009;54:718–26.CrossRefPubMed Rider OJ, Francis JM, Ali MK, Petersen SE, Robinson M, Robson MD, et al. Beneficial cardiovascular effects of bariatric surgical and dietary weight loss in obesity. J Am Coll Cardiol. 2009;54:718–26.CrossRefPubMed
68.
Zurück zum Zitat Ikonomidis I, Mazarakis A, Papadopoulos C, Patsouras N, Kalfarentzos F, Lekakis J, et al. Weight loss after bariatric surgery improves aortic elastic properties and left ventricular function in individuals with morbid obesity: a 3-year follow-up study. J Hypertens. 2007;25:439–47.CrossRefPubMed Ikonomidis I, Mazarakis A, Papadopoulos C, Patsouras N, Kalfarentzos F, Lekakis J, et al. Weight loss after bariatric surgery improves aortic elastic properties and left ventricular function in individuals with morbid obesity: a 3-year follow-up study. J Hypertens. 2007;25:439–47.CrossRefPubMed
69.
Zurück zum Zitat Willens HJ, Chakko SC, Byers P, Chirinos JA, Labrador E, Castrillon JC, et al. Effects of weight loss after gastric bypass on right and left ventricular function assessed by tissue Doppler imaging. Am J Cardiol. 2005;95:1521–4.CrossRefPubMed Willens HJ, Chakko SC, Byers P, Chirinos JA, Labrador E, Castrillon JC, et al. Effects of weight loss after gastric bypass on right and left ventricular function assessed by tissue Doppler imaging. Am J Cardiol. 2005;95:1521–4.CrossRefPubMed
70.
Zurück zum Zitat Garza CA, Pellikka PA, Somers VK, Sarr MG, Collazo-Clavell ML, Korenfeld Y, et al. Structural and functional changes in left and right ventricles after major weight loss following bariatric surgery for morbid obesity. Am J Cardiol. 2010;105:550–6.CrossRefPubMed Garza CA, Pellikka PA, Somers VK, Sarr MG, Collazo-Clavell ML, Korenfeld Y, et al. Structural and functional changes in left and right ventricles after major weight loss following bariatric surgery for morbid obesity. Am J Cardiol. 2010;105:550–6.CrossRefPubMed
71.
Zurück zum Zitat Shah RV, Murthy VL, Abbasi SA, Eng J, Wu C, Ouyang P, et al. Weight loss and progressive left ventricular remodelling: the multi-ethnic study of atherosclerosis (MESA). Eur J Prev Cardiol. 2014;22:1408–18.CrossRefPubMedPubMedCentral Shah RV, Murthy VL, Abbasi SA, Eng J, Wu C, Ouyang P, et al. Weight loss and progressive left ventricular remodelling: the multi-ethnic study of atherosclerosis (MESA). Eur J Prev Cardiol. 2014;22:1408–18.CrossRefPubMedPubMedCentral
72.
Zurück zum Zitat Leichman J, Wilson E, Scarborough T, Aguilar D, Miller C, Yu S, et al. Dramatic reversal of derangements in muscle metabolism and left ventricular function after bariatric surgery. Am J Med. 2008;121:966–73.CrossRefPubMedPubMedCentral Leichman J, Wilson E, Scarborough T, Aguilar D, Miller C, Yu S, et al. Dramatic reversal of derangements in muscle metabolism and left ventricular function after bariatric surgery. Am J Med. 2008;121:966–73.CrossRefPubMedPubMedCentral
73.
Zurück zum Zitat Kanoupakis E, Michaloudis D, Fraidakis O, Parthenakis F, Vardas P, Melissas J. Left ventricular function and cardiopulmonary performance following surgical treatment of morbid obesity. Obes Surg. 2001;11:552–8.CrossRefPubMed Kanoupakis E, Michaloudis D, Fraidakis O, Parthenakis F, Vardas P, Melissas J. Left ventricular function and cardiopulmonary performance following surgical treatment of morbid obesity. Obes Surg. 2001;11:552–8.CrossRefPubMed
74.
Zurück zum Zitat Di Bello V, Santini F, Di Cori A, Pucci A, Talini E, Palagi C, et al. Effects of bariatric surgery on early myocardial alterations in adult severely obese subjects. Cardiology. 2008;109:241–8.CrossRefPubMed Di Bello V, Santini F, Di Cori A, Pucci A, Talini E, Palagi C, et al. Effects of bariatric surgery on early myocardial alterations in adult severely obese subjects. Cardiology. 2008;109:241–8.CrossRefPubMed
75.
Zurück zum Zitat Koshino Y, Villarraga HR, Somers VK, Miranda WR, Garza CA, Hsiao J-F, et al. Changes in myocardial mechanics in patients with obesity following major weight loss after bariatric surgery. Obesity. 2013;21:1111–8.CrossRefPubMed Koshino Y, Villarraga HR, Somers VK, Miranda WR, Garza CA, Hsiao J-F, et al. Changes in myocardial mechanics in patients with obesity following major weight loss after bariatric surgery. Obesity. 2013;21:1111–8.CrossRefPubMed
76.
Zurück zum Zitat • Kaier TE, Morgan D, Grapsa J, Demir OM, Paschou SA, Sundar S, et al. Ventricular remodelling post-bariatric surgery: is the type of surgery relevant? A prospective study with 3D speckle tracking. Eur Heart J Cardiovasc Imaging. 2014;15:1256–62. A single-center study of obese patients without HF, highlighting the regression of biventricular hypertrophy and abnormal global longitudinal strain that follows successful surgical weight loss . CrossRefPubMed • Kaier TE, Morgan D, Grapsa J, Demir OM, Paschou SA, Sundar S, et al. Ventricular remodelling post-bariatric surgery: is the type of surgery relevant? A prospective study with 3D speckle tracking. Eur Heart J Cardiovasc Imaging. 2014;15:1256–62. A single-center study of obese patients without HF, highlighting the regression of biventricular hypertrophy and abnormal global longitudinal strain that follows successful surgical weight loss . CrossRefPubMed
77.
Zurück zum Zitat •• Benotti PN, Wood GC, Carey DJ, Mehra VC, Mirshahi T, Lent MR, et al. Gastric bypass surgery produces a durable reduction in cardiovascular disease risk factors and reduces the long-term risks of congestive heart failure. J Am Heart Assoc. 2017;6:e005126. A cohort of RYGB patients was compared to a matched cohort of non-surgical obese patients, with follow-up for up to 12 years ( n = 1724 per cohort). There was a significantly lower rate of the composite cardiovascular endpoint in surgical group, as well as a lower rate of incident HF. CrossRefPubMedPubMedCentral •• Benotti PN, Wood GC, Carey DJ, Mehra VC, Mirshahi T, Lent MR, et al. Gastric bypass surgery produces a durable reduction in cardiovascular disease risk factors and reduces the long-term risks of congestive heart failure. J Am Heart Assoc. 2017;6:e005126. A cohort of RYGB patients was compared to a matched cohort of non-surgical obese patients, with follow-up for up to 12 years ( n= 1724 per cohort). There was a significantly lower rate of the composite cardiovascular endpoint in surgical group, as well as a lower rate of incident HF. CrossRefPubMedPubMedCentral
78.
Zurück zum Zitat •• Persson CE, Björck L, Lagergren J, Lappas G, Giang KW, Rosengren A. Risk of heart failure in obese patients with and without bariatric surgery in Sweden—a registry-based study. J Card Fail. 2017;23:530–7. A cohort of 22,295 obese patients who underwent bariatric surgery (mostly RYGB) was compared to 25,564 obese patients who were managed non-surgically in Sweden. Even after covariate adjustment, the hazard of HF development was significantly lower in the surgical group than the non-surgical group. CrossRefPubMed •• Persson CE, Björck L, Lagergren J, Lappas G, Giang KW, Rosengren A. Risk of heart failure in obese patients with and without bariatric surgery in Sweden—a registry-based study. J Card Fail. 2017;23:530–7. A cohort of 22,295 obese patients who underwent bariatric surgery (mostly RYGB) was compared to 25,564 obese patients who were managed non-surgically in Sweden. Even after covariate adjustment, the hazard of HF development was significantly lower in the surgical group than the non-surgical group. CrossRefPubMed
79.
Zurück zum Zitat •• Sundström J, Bruze G, Ottosson J, Marcus C, Näslund I, Neovius M. Weight loss and heart failure: a nationwide study of gastric bypass surgery versus intensive lifestyle treatment. Circulation. 2017;135:1577–85. Patients who received bariatric surgery in the Scandinavian Obesity Surgery Registry ( n = 25,804) were compared to a nationwide registry of patients receiving a structured intensive lifestyle program ( n = 13,701) for obesity management. Over a median 4-year follow-up, surgical patients had a significantly lower hazard of HF development than the lifestyle modification patients. CrossRefPubMedPubMedCentral •• Sundström J, Bruze G, Ottosson J, Marcus C, Näslund I, Neovius M. Weight loss and heart failure: a nationwide study of gastric bypass surgery versus intensive lifestyle treatment. Circulation. 2017;135:1577–85. Patients who received bariatric surgery in the Scandinavian Obesity Surgery Registry ( n= 25,804) were compared to a nationwide registry of patients receiving a structured intensive lifestyle program ( n= 13,701) for obesity management. Over a median 4-year follow-up, surgical patients had a significantly lower hazard of HF development than the lifestyle modification patients. CrossRefPubMedPubMedCentral
80.
Zurück zum Zitat Jamaly S, Carlsson L, Peltonen M, Jacobson P, Sjöström L, Karason K. Bariatric surgery and the risk of new-onset atrial fibrillation in Swedish obese subjects. J Am Coll Cardiol. 2016;68:2497–504.CrossRefPubMedPubMedCentral Jamaly S, Carlsson L, Peltonen M, Jacobson P, Sjöström L, Karason K. Bariatric surgery and the risk of new-onset atrial fibrillation in Swedish obese subjects. J Am Coll Cardiol. 2016;68:2497–504.CrossRefPubMedPubMedCentral
81.
Zurück zum Zitat Wing RR, Lang W, Wadden TA, Safford M, Knowler WC, Bertoni AG, et al. Look AHEAD research group. Benefits of modest weight loss in improving cardiovascular risk factors in overweight and obese individuals with type 2 diabetes. Diabetes Care. 2011;34:1481–6.CrossRefPubMedPubMedCentral Wing RR, Lang W, Wadden TA, Safford M, Knowler WC, Bertoni AG, et al. Look AHEAD research group. Benefits of modest weight loss in improving cardiovascular risk factors in overweight and obese individuals with type 2 diabetes. Diabetes Care. 2011;34:1481–6.CrossRefPubMedPubMedCentral
82.
Zurück zum Zitat Douketis JD, Macie C, Thabane L, Williamson DF. Systematic review of long-term weight loss studies in obese adults: clinical significance and applicability to clinical practice. Int J Obes Relat Metab Disord. 2005;29:1153–67.CrossRef Douketis JD, Macie C, Thabane L, Williamson DF. Systematic review of long-term weight loss studies in obese adults: clinical significance and applicability to clinical practice. Int J Obes Relat Metab Disord. 2005;29:1153–67.CrossRef
83.
Zurück zum Zitat Pritchett AM, Deswal A, Aguilar D, Foreyt JP, Chan W, Mann DL, et al. Lifestyle modification with diet and exercise in obese patients with heart failure—a pilot study. J Obes Weight Loss Ther. 2012;2:1–8.CrossRefPubMedPubMedCentral Pritchett AM, Deswal A, Aguilar D, Foreyt JP, Chan W, Mann DL, et al. Lifestyle modification with diet and exercise in obese patients with heart failure—a pilot study. J Obes Weight Loss Ther. 2012;2:1–8.CrossRefPubMedPubMedCentral
84.
Zurück zum Zitat Evangelista LS, Heber D, Li Z, Bowerman S, Hamilton MA, Fonarow GC. Reduced body weight and adiposity with a high-protein diet improves functional status, lipid profiles, glycemic control, and quality of life in patients with heart failure: a feasibility study. J Cardiovasc Nurs. 2009;24:207–15.CrossRefPubMedPubMedCentral Evangelista LS, Heber D, Li Z, Bowerman S, Hamilton MA, Fonarow GC. Reduced body weight and adiposity with a high-protein diet improves functional status, lipid profiles, glycemic control, and quality of life in patients with heart failure: a feasibility study. J Cardiovasc Nurs. 2009;24:207–15.CrossRefPubMedPubMedCentral
85.
Zurück zum Zitat O'Connor CM, Whellan DJ, Lee KL, Keteyian SJ, Cooper LS, Ellis SJ, et al. Efficacy and safety of exercise training in patients with chronic heart failure: HF-ACTION randomized controlled trial. JAMA. 2009;301:1439–50.CrossRefPubMedPubMedCentral O'Connor CM, Whellan DJ, Lee KL, Keteyian SJ, Cooper LS, Ellis SJ, et al. Efficacy and safety of exercise training in patients with chronic heart failure: HF-ACTION randomized controlled trial. JAMA. 2009;301:1439–50.CrossRefPubMedPubMedCentral
86.
Zurück zum Zitat Flynn KE, Piña IL, Whellan DJ, Lin L, Blumenthal JA, Ellis SJ, et al. Effects of exercise training on health status in patients with chronic heart failure: HF-ACTION randomized controlled trial. JAMA. 2009;301:1451–9.CrossRefPubMedPubMedCentral Flynn KE, Piña IL, Whellan DJ, Lin L, Blumenthal JA, Ellis SJ, et al. Effects of exercise training on health status in patients with chronic heart failure: HF-ACTION randomized controlled trial. JAMA. 2009;301:1451–9.CrossRefPubMedPubMedCentral
87.
Zurück zum Zitat Horwich TB, Broderick S, Chen L, McCullough PA, Strzelczyk T, Kitzman DW, et al. Relation among body mass index, exercise training, and outcomes in chronic systolic heart failure. Am J Cardiol. 2011;108:1754–9.CrossRefPubMedPubMedCentral Horwich TB, Broderick S, Chen L, McCullough PA, Strzelczyk T, Kitzman DW, et al. Relation among body mass index, exercise training, and outcomes in chronic systolic heart failure. Am J Cardiol. 2011;108:1754–9.CrossRefPubMedPubMedCentral
88.
Zurück zum Zitat Li Z, Maglione M, Tu W, Mojica W, Arterburn D, Shugarman LR, et al. Meta-analysis: pharmacologic treatment of obesity. Ann Intern Med. 2005;142:532–46.CrossRefPubMed Li Z, Maglione M, Tu W, Mojica W, Arterburn D, Shugarman LR, et al. Meta-analysis: pharmacologic treatment of obesity. Ann Intern Med. 2005;142:532–46.CrossRefPubMed
89.
Zurück zum Zitat Beck-da-Silva L, Higginson L, Fraser M, Williams K, Haddad H. Effect of Orlistat in obese patients with heart failure: a pilot study. Congest Heart Fail. 2005;11:118–23.CrossRefPubMed Beck-da-Silva L, Higginson L, Fraser M, Williams K, Haddad H. Effect of Orlistat in obese patients with heart failure: a pilot study. Congest Heart Fail. 2005;11:118–23.CrossRefPubMed
90.
Zurück zum Zitat Zuber M, Kaeslin T, Studer T, Erne P. Weight loss of 146 kg with diet and reversal of severe congestive heart failure in a young, morbidly obese patient. Am J Cardiol. 1999;84:955–6.CrossRefPubMed Zuber M, Kaeslin T, Studer T, Erne P. Weight loss of 146 kg with diet and reversal of severe congestive heart failure in a young, morbidly obese patient. Am J Cardiol. 1999;84:955–6.CrossRefPubMed
91.
Zurück zum Zitat Iyengar S, Leier C. Rescue bariatric surgery for obesity-induced cardiomyopathy. Am J Med. 2006;119:e5–e6.CrossRef Iyengar S, Leier C. Rescue bariatric surgery for obesity-induced cardiomyopathy. Am J Med. 2006;119:e5–e6.CrossRef
92.
Zurück zum Zitat Ristow B, Rabkin J, Haeusslein E. Improvement in dilated cardiomyopathy after bariatric surgery. J Card Fail. 2008;14:198–202.CrossRefPubMed Ristow B, Rabkin J, Haeusslein E. Improvement in dilated cardiomyopathy after bariatric surgery. J Card Fail. 2008;14:198–202.CrossRefPubMed
93.
Zurück zum Zitat Alpert MA, Terry BE, Kelly DL. Effect of weight loss on cardiac chamber size, wall thickness and left ventricular function in morbid obesity. Am J Cardiol. 1985;55:783–6.CrossRefPubMed Alpert MA, Terry BE, Kelly DL. Effect of weight loss on cardiac chamber size, wall thickness and left ventricular function in morbid obesity. Am J Cardiol. 1985;55:783–6.CrossRefPubMed
94.
Zurück zum Zitat Alpert MA, Terry BE, Mulekar M, Cohen MV, Massey CV, Fan TM. Cardiac morphology and left ventricular function in normotensive morbidly obese patients with and without congestive heart failure, and effect of weight loss. Am J Cardiol. 1997;80:736–40.CrossRefPubMed Alpert MA, Terry BE, Mulekar M, Cohen MV, Massey CV, Fan TM. Cardiac morphology and left ventricular function in normotensive morbidly obese patients with and without congestive heart failure, and effect of weight loss. Am J Cardiol. 1997;80:736–40.CrossRefPubMed
95.
Zurück zum Zitat McCloskey CA, Ramani GV, Mathier MA, Schauer PR, Eid GM, Mattar SG, et al. Bariatric surgery improves cardiac function in morbidly obese patients with severe cardiomyopathy. Surg Obes Relat Dis. 2007;3:503–7.CrossRefPubMed McCloskey CA, Ramani GV, Mathier MA, Schauer PR, Eid GM, Mattar SG, et al. Bariatric surgery improves cardiac function in morbidly obese patients with severe cardiomyopathy. Surg Obes Relat Dis. 2007;3:503–7.CrossRefPubMed
96.
Zurück zum Zitat Ramani GV, McCloskey C, Ramanathan RC, Mathier MA. Safety and efficacy of bariatric surgery in morbidly obese patients with severe systolic heart failure. Clin Cardiol. 2008;31:516–20.CrossRefPubMed Ramani GV, McCloskey C, Ramanathan RC, Mathier MA. Safety and efficacy of bariatric surgery in morbidly obese patients with severe systolic heart failure. Clin Cardiol. 2008;31:516–20.CrossRefPubMed
97.
Zurück zum Zitat •• Shimada YJ, Tsugawa Y, Brown DFM, Hasegawa K. Bariatric surgery and emergency department visits and hospitalizations for heart failure exacerbation: population-based, self-controlled series. J Am Coll Cardiol. 2015;67:895–903. This was the first analysis of HF hospitalizations/emergency room visits for patients with obesity before and after bariatric surgery, using data from 3 US states. Amongst 524 patients, 16.2% had a HF hospitalization/emergency room visit in the time period 13–24 months prior to bariatric surgery. There was a non-significant reduction in HF visits in the first 12 months after bariatric surgery and a significantly reduction in months 13–24 after bariatric surgery (to 9.9%). CrossRef •• Shimada YJ, Tsugawa Y, Brown DFM, Hasegawa K. Bariatric surgery and emergency department visits and hospitalizations for heart failure exacerbation: population-based, self-controlled series. J Am Coll Cardiol. 2015;67:895–903. This was the first analysis of HF hospitalizations/emergency room visits for patients with obesity before and after bariatric surgery, using data from 3 US states. Amongst 524 patients, 16.2% had a HF hospitalization/emergency room visit in the time period 13–24 months prior to bariatric surgery. There was a non-significant reduction in HF visits in the first 12 months after bariatric surgery and a significantly reduction in months 13–24 after bariatric surgery (to 9.9%). CrossRef
98.
Zurück zum Zitat Chaudhry UI, Kanji A, Sai-Sudhakar CB, Higgins RS, Needleman BJ. Laparoscopic sleeve gastrectomy in morbidly obese patients with end-stage heart failure and left ventricular assist device: medium-term results. Surg Obes Relat Dis. 2015;11:88–93.CrossRefPubMed Chaudhry UI, Kanji A, Sai-Sudhakar CB, Higgins RS, Needleman BJ. Laparoscopic sleeve gastrectomy in morbidly obese patients with end-stage heart failure and left ventricular assist device: medium-term results. Surg Obes Relat Dis. 2015;11:88–93.CrossRefPubMed
99.
Zurück zum Zitat Greene J, Tran T, Shope T. Sleeve gastrectomy and left ventricular assist device for heart transplant. JSLS. 2017;21:e 2017.00049.CrossRef Greene J, Tran T, Shope T. Sleeve gastrectomy and left ventricular assist device for heart transplant. JSLS. 2017;21:e 2017.00049.CrossRef
Metadaten
Titel
Has the Time Come to Be More Aggressive With Bariatric Surgery in Obese Patients With Chronic Systolic Heart Failure?
verfasst von
Amanda R. Vest
Publikationsdatum
08.04.2018
Verlag
Springer US
Erschienen in
Current Heart Failure Reports / Ausgabe 3/2018
Print ISSN: 1546-9530
Elektronische ISSN: 1546-9549
DOI
https://doi.org/10.1007/s11897-018-0390-z

Weitere Artikel der Ausgabe 3/2018

Current Heart Failure Reports 3/2018 Zur Ausgabe

Management of Heart Failure (T. Meyer, Section Editor)

Essential Elements of Early Post Discharge Care of Patients with Heart Failure

Pharmacologic Therapy (W.H.W. Tang, Section Editor)

Novel Insights and Treatment Strategies for Right Heart Failure

Pharmacologic Therapy (W.H.W. Tang, Section Editor)

Nutritional Interventions in Heart Failure: Challenges and Opportunities

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.